Q1 2019 13F Holders as of 3/31/2019
-
Type / Class
-
Equity / Common Shares
-
Shares outstanding
-
71.9M
-
Number of holders
-
19
-
Total 13F shares, excl. options
-
11.9M
-
Shares change
-
-82.9K
-
Total reported value, excl. options
-
$76.8M
-
Value change
-
-$564K
-
Number of buys
-
5
-
Number of sells
-
-10
-
Price
-
$6.47
Significant Holders of SINOVAC BIOTECH LTD. - Common Shares (SVA) as of Q1 2019
26 filings reported holding SVA - SINOVAC BIOTECH LTD. - Common Shares as of Q1 2019.
SINOVAC BIOTECH LTD. - Common Shares (SVA) has 19 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 11.9M shares
of 71.9M outstanding shares and own 16.51% of the company stock.
Largest 10 shareholders include Vivo Capital, LLC (5.9M shares), ORBIMED ADVISORS LLC (2.84M shares), RENAISSANCE TECHNOLOGIES LLC (2.38M shares), Neumann Advisory Hong Kong Ltd (316K shares), STATE STREET CORP (161K shares), Yorktown Management & Research Co Inc (74.9K shares), CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM (68.7K shares), GEODE CAPITAL MANAGEMENT, LLC (27.7K shares), RAMSEY QUANTITATIVE SYSTEMS (23.1K shares), and NORTHERN TRUST CORP (22.4K shares).
This table shows the top 19 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.